ClinicalTrials.gg
Not yet recruitingNCT06853054Updated Aug 1, 2025

Seeking for Perfected Aortic Arch Reconstruction Using a Graphically Designed Patient-specific Surgical Patch

An interventional study of Personalized patch template in Hypoplastic Left Heart Syndrome (HLHS) and Aortic Arch Hypoplasia, sponsored by The Hospital for Sick Children. Not yet recruiting at 1 site in Canada. Open to participants aged 0 Months to 2 Months. Per ClinicalTrials.gov, last updated 2025-08-01.

Sponsored by The Hospital for Sick Children · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
0 Months to 2 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Hypoplastic Left Heart Syndrome with a site in Canada — 4 open to participants now, 5 under way, 1 of them phase 3. Hypoplastic Left Heart Syndrome · Canada.

Started
2025
the only one that year
No phase
5 of 13
1 open now
Registered
13th of 13
by date
Lead sponsor
3 of 13
The Hospital for Sick Children

Among the 13 studies in Hypoplastic Left Heart Syndrome with a site in Canada, this one is the only one that started in 2025, is one of 5 with no phase, and was the 13th registered.

Hypoplastic Left Heart Syndrome

67 studies on the registry are indexed under Hypoplastic Left Heart Syndrome; 12 are open to participants now.

Browse Hypoplastic Left Heart Syndrome studies →

Open to participants now

4 of the 13 studies in Hypoplastic Left Heart Syndrome with a site in Canada are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 9 Hypoplastic Left Heart Syndrome studies recruiting now, 3 set no upper age limit and 6 stop at 75 or younger; 9 take children under 18; none take healthy volunteers.

This study: 0 Months to 2 Months · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Hypoplastic Left Heart Syndrome with a site in Canada, or all of them as a file.
02

Study summary

Vascular Reconstruction is one of the most challenging areas of surgery, the surgeon has to create a completely watertight reconstruction without any narrowing or deformity that will restore normal flow characteristics, even at high pressures. Nowhere is this more challenging than in neonatal heart surgery where babies born with aortic arch narrowing or underdevelopment are one of the commonest life-threatening cardiovascular conditions.

Reconstruction not only has to recreate normal anatomy but also allow for subsequent growth and development.

Until now, surgical reconstruction depended on the surgeon's subjective assessment of the anatomy and a best estimate of patch shaping and design. New engineering techniques have enabled us to create 3D printed models of real hearts and then recreate the actual surgery on these models using a variety of engineered patches and different surgical techniques. These reconstructed models can now be placed in flow-testing rigs and undergo 4-dimensional flow imaging to provide high-fidelity velocity and shear force analysis that allow for precision design of the ideal geometry to give optimal flow.

This project will combine the skills of the largest team of neonatal heart surgeons in Canada, working with cardiac imaging experts, physicists and biomechanical engineers who are recognized as the world leaders in 3D printing technologies for congenital heart disease. Using a series of rigorous repeated tests and different designs we will define the ideal techniques and patch shapes and then translate this to real cases where a precision-shaped personalized patch can be created for each individual. Following up these babies as they grow with precision 3D scanning will show how these vessels are growing. Our mathematics-driven approach will make the surgery easier, shorter and more efficient. It will also provide more consistent surgical results among surgeons.

Read the detailed description

Aortic arch reconstruction complications can be prevented or minimalized by personalizing the surgical technique and patch through mathematical computer modeling and 3D printing.

This is a feasibility study on the use of graphical 3D printing and flow modelling in the creation of personalized patch templates for the Norwood procedure and aortic arch reconstruction.

Patients undergoing the Norwood procedure as part of standard of care will be approached for consent. Patients who consent to the study will undergo a pre-operative contrast CT scan to design simulation models and to identify the most ideal aortic arch configuration. 3D printing of the sterilizable template will be done after computer-aided design of bespoke surgical patches and will be based on pre-operative imaging and simulation. The sterilizable patch template will be used by the surgeon as a guide to fashioning the precise size and shape of the patch.

A research CT scan will be done post-operatively, prior to patient discharge. The post-op CT scan will be used to create a 3D printed model of the reconstructed aortic arch, This 3D printed model will then undergo 4D MRI scanning as part of the analysis.

Patients will be monitored and followed closely post-surgery. They will be assessed by routine post-operative tests including standard of care imaging at 4-6 months after surgery.

Clinical outcome assessment at 6-12 months after surgery will be measured.

This data will be compared to surgical outcomes of a historical cohort of patients who had traditional patches.

03

Conditions studied

  • Hypoplastic Left Heart Syndrome (HLHS)
  • Aortic Arch Hypoplasia

Keywords

  • Congenital heart surgery
  • Aortic arch reconstruction
  • Surgical patch
  • Computer-aided design
  • 3D modeling and printing
04

Who can participate

Ages eligible
0 Months to 2 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Newborns, 0-2 months of age
  • Requiring a Norwood procedure and aortic arch reconstruction
  • Consent provided

Exclusion criteria

Exclusion Criteria:

  • Consent not provided
  • to contrast CT scans (allergy to contrast, kidney disease)
  • Any condition or diagnosis, that could in the opinion of the Principal Investigator or delegate interfere with the participant's ability to comply with the study, might confound the interpretation of the study results, or put the participant at risk
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Personalized Patch Template

    Using each participant's pre-operative imaging, the most ideal aortic arch configuration will be identified. This will be followed by simulation of mechanical effects on the adjacent structures by overlapping the designed aortic arch model on the participant's original images. Computer-aided design of the personalized patch template will then be completed and followed by 3D printing of the sterilizable, personalized patch template.

    Procedure: Personalized patch template

Interventions

  • ProcedurePersonalized patch template

    The personalized, sterilizable patch template will be used as the surgeon's guide in fashioning the precise size and shape of the surgical patch.

06

What researchers measure

Primary outcomes

  1. Survival Rate (%): patient status (Alive/Dead)

    Survival will be recorded based on patient status at the time of discharge (in-hospital), 30 days post-surgery, and at 1-year follow-up. The unit of measure will be the percentage of patients who remain alive at each of these time points.

    Time frame: In hospital, at 30 days and at 1 year follow-up

  2. Hemodynamic Stability: Inotrope Requirement (daily score)

    A scale measuring the need for inotropic support, based on the number and type of inotropic medications required. Inotropic support will be quantified on a daily score (ranging from 0 to a maximum score depending on inotrope usage).

    Time frame: Post-op Day 1: Initial assessment within 24 hours of surgery, Post-op Days 2-7: Daily assessments during the first week post-surgery, 1 month, 6 months, 1 year follow up: Evaluation of ongoing hemodynamic stability

  3. Hemodynamic Stability: Blood pressure

    Measured in mmHg using a standard non-invasive sphygmomanometer or an arterial catheter for continuous measurement in the ICU.

    Time frame: Post-op Day 1: Initial assessment within 24 hours of surgery, Post-op Days 2-7: Daily assessments during the first week post-surgery, 1 month, 6 months, 1 year follow up: Evaluation of ongoing hemodynamic stability

  4. Hemodynamic Stability: Heart Rate

    Measured in beats per minute (bpm) using ECG or pulse oximeter.

    Time frame: Post-op Day 1: Initial assessment within 24 hours of surgery, Post-op Days 2-7: Daily assessments during the first week post-surgery, 1 month, 6 months, 1 year follow up: Evaluation of ongoing hemodynamic stability

  5. Hemodynamic Stability: Oxygen Saturations (SpO2)

    Measured as a percentage (%) using a pulse oximeter.

    Time frame: Post-op Day 1: Initial assessment within 24 hours of surgery, Post-op Days 2-7: Daily assessments during the first week post-surgery, 1 month, 6 months, 1 year follow up: Evaluation of ongoing hemodynamic stability

Secondary outcomes

  1. Need for Re-intervention or Additional Surgeries (%)

    Patient status (Need for re-exploration, reoperation, or catheter-based interventions) measured by the percentage (%) of patients requiring additional surgical or catheter-based interventions.

    Time frame: During hospitalization, at 1 Month, 6 Months, and 1 Year Follow-up

  2. Incidence of Post-operative Complications (%)

    Percentage (%) of patients with complications (e.g., renal dysfunction, infection, bleeding, metabolic distress)

    Time frame: Post-op Days 1-3, Post-op days 4-7, Post Discharge (1 month, 6 months, 1 year)

  3. Growth Parameters at Follow-up: Weight

    Measurement of weight in kg

    Time frame: At hospital discharge, at 1 Month, 6 Months, and 1 Year follow-up

  4. Growth Parameters at Follow-up: Height

    Measurement of height (cm)

    Time frame: At hospital discharge, at 1 Month, 6 Months, and 1 Year follow-up

  5. Growth Parameters at Follow-up: Oxygen saturation in %

    Measurement of oxygen saturation SpO2 (%)

    Time frame: At hospital discharge, at 1 Month, 6 Months, and 1 Year follow-up

  6. Aortic Arch Dimensions (mm)

    Aortic arch dimensions in mm (measured in different sections of the arch: ascending aorta, proximal, distal, isthmus).

    Time frame: At pre-op, post-op day 1, and at follow-up: a 1 month, 6 months and 1 year post surgery

  7. Flow velocity

    Flow velocity in cm/s (measured using Doppler ultrasound or MRI 4D flow study).

    Time frame: At pre-op, post-op day 1, and at follow-up: a 1 month, 6 months and 1 year post surgery

  8. Cardiac Function (Ventricular Function and Valve Regurgitation) and Heart Structure (Atrial Septum Integrity)

    Qualitative assessment of ventricular function, the atrial septum, tricuspid regurgitation and neo-aortic regurgitation through echocardiography

    Time frame: At pre-op, post-op day 1, and at follow-up: a 1 month, 6 months and 1 year post surgery

  9. Long-term Reintervention or Complications

    Percentage (%) of patients requiring reintervention or experiencing complications

    Time frame: At 1 month, 6 months, and 1 year follow-up

  10. Incidence of Structural Issues (Pulmonary or Bronchial Compression) (%)

    Percentage (%) of patients with left pulmonary artery compression, left main bronchus compression, or aortic arch tortuosity as measured by CT or MRI scans.

    Time frame: At post-op Day 1 and at 1 month, 6 months and 1 year follow-up

07

Study locations

1 site
  • The Hospital for Sick Children
    Toronto, Ontario M5G 3X8, Canada
    • Cristina Salvo · Contactcristina.salvo@sickkids.ca · 416-813-7654
    • Rita Nobile · Contactrita.nobile@sickkids.ca · 416-813-7500
    • Israel Valverde · Principal investigator
    • David Barron · Sub investigator
    • Shi-Joon Yoo · Sub investigator
    • Osami Honjo · Sub investigator
    • Christopher Macgowan · Sub investigator
    • Christoph Haller · Sub investigator
    • Owais Khan · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2025; primary completion for Jan 2028, 28 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 7, 2024
First posted
Feb 28, 2025
StartEst.
Sep 1, 2025
Primary completionEst.
Jan 2028
CompletionEst.
Dec 2028
Last update
Aug 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06853054
Collaborators
Canadian Institutes of Health Research (CIHR)
Responsible party
Shi-Joon Yoo (Staff Cardiac Radiologist, Division of Cardiac Imaging, Department of Diagnostic Imaging, The Hospital for Sick Children) — Principal investigator
First posted
Feb 28, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
Jan 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Aug 1, 2025

Study contacts

Cristina Salvo
Contact
cristina.salvo@sickkids.ca
416-813-7654 ext. 228847

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion